Product How it works Pricing Blog FAQ About Contact
Zentalis Pharmaceuticals

Zentalis Pharmaceuticals (NASDAQ: ZNTL) revenue

Zentalis Pharmaceuticals reported revenue of $0.0m for fiscal 2025, 100.0% less than in fiscal 2024 ($67.4m).

Zentalis Pharmaceuticals's best year of the last 4 was fiscal 2024.

Revenue, in millions of US dollars0.020220.0202367.420240.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$0.0m−100.0%−$152.8m—
2024$67.4m—−$191.2m−283.6%
2023$0.0m—−$299.5m—
2022$0.0m—−$227.3m—

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Zentalis Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Zentalis Pharmaceuticals ranks 422nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Zentalis Pharmaceuticals, −100.0%.

RankCompanyRevenueRevenue growth
418thSpruce Biosciences$0.0m−100.0%
419thScholar Rock$0.0m—
420thSpyre Therapeutics$0.0m—
421stTenax Therapeutics$0.0m—
422ndZentalis Pharmaceuticals$0.0m−100.0%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Zentalis Pharmaceuticals

How much revenue did Zentalis Pharmaceuticals make in fiscal 2025?
Zentalis Pharmaceuticals reported revenue of $0.0m for fiscal 2025, compared with $67.4m in fiscal 2024.
What was the best year for revenue at Zentalis Pharmaceuticals?
Of its last 4 fiscal years, fiscal 2024, with $67.4m.
Where does Zentalis Pharmaceuticals rank in its sector by revenue?
It ranks 422nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Zentalis Pharmaceuticals come from?
From the annual report (Form 10-K) that Zentalis Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Zentalis Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022. More on Zentalis Pharmaceuticals: the Zentalis Pharmaceuticals page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.